Enovis™ Announces Leadership Change to International Surgical Business

Core Insights - Enovis has announced that Davide Visentin will succeed Dr. Benjamin Reinmann as President of Enovis International Surgical, effective March 1, 2025 [1][2] Company Leadership Transition - Davide Visentin brings over 20 years of healthcare experience, previously serving as Vice President and General Manager at BD, managing over 700 employees across 50 countries [2] - Visentin has also held leadership roles at Stryker and Johnson & Johnson, indicating a strong background in the MedTech industry [2][3] - Louie Vogt, Group President of Enovis' Reconstructive Business Group, expressed gratitude for Dr. Reinmann's contributions and excitement for Visentin's leadership, highlighting his dynamic leadership and passion for orthopedics [3] Business Growth and Strategy - Enovis is focused on building its International Surgical Business into a global leader in orthopedics, emphasizing a commitment to excellence and innovation [4] - The company aims to leverage the momentum gained in 2024 to advance strategic goals, increase market share, and improve patient outcomes [4]